First nonprescription birth control pill approved by FDA
The oral contraceptive’s maker, Perrigo, said the pill will be available in drug and grocery stores early next year, but did not disclose its planned price.
The oral contraceptive’s maker, Perrigo, said the pill will be available in drug and grocery stores early next year, but did not disclose its planned price.
Nearly two million people have been disenrolled from Medicaid to date, but it’s too early to get a full picture of redeterminations’ effect on vulnerable Americans, experts say.
Variable race and ethnicity data is making it difficult to determine whether CMS Innovation Center models are reaching, enrolling and helping underserved beneficiaries, according to a new white paper from the agency.
The program will be a source of revenue for GoodRx, and might also open a new fee stream for CVS’ pharmacy benefit manager as the drug middlemen face increased scrutiny for complex pricing models.
The suit alleges that the health system failed to implement safeguards to secure patients’ health information and provided insufficient details about the stolen data.
Product leaders ensure the integrity and usability of data for care, patient engagement and analytics.
Two years after an overhaul designed to decrease documentation burden, clinicians are writing even longer notes, according to Epic Research.
Rock Health’s latest report found U.S. startups raised $6.1 billion across 244 deals in the first half of 2023. If investment stays at the same pace, the sector is facing its lowest funding year since 2019.
With consumers increasingly tapping medical credit cards to pay for healthcare costs, the Biden administration is zeroing in on regulations to police such financial services.
Hospital groups said the proposed rule is an important step toward restitution for years of 340B underpayments, but they criticized regulators for proposed rate decreases and a lack of additional interest payments.